| Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach … HG van der Poel, T Buckle, OR Brouwer, RAV Olmos, FWB van Leeuwen European urology 60 (4), 826-833, 2011 | 378 | 2011 |
| Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma SWM Bruggeman, D Hulsman, E Tanger, T Buckle, M Blom, ... Cancer cell 12 (4), 328-341, 2007 | 337 | 2007 |
| P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan NA de Vries, J Zhao, E Kroon, T Buckle, JH Beijnen, O Van Tellingen Clinical Cancer Research 13 (21), 6440-6449, 2007 | 318 | 2007 |
| Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met J Burggraaf, IMC Kamerling, PB Gordon, L Schrier, ML De Kam, AJ Kales, ... Nature medicine 21 (8), 955-961, 2015 | 289 | 2015 |
| Comparing the hybrid fluorescent–radioactive tracer indocyanine green–99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using … OR Brouwer, T Buckle, L Vermeeren, WMC Klop, AJM Balm, ... Journal of Nuclear Medicine 53 (7), 1034-1040, 2012 | 254 | 2012 |
| Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies … S Marchetti, NA de Vries, T Buckle, MJ Bolijn, MAJ van Eijndhoven, ... Molecular cancer therapeutics 7 (8), 2280-2287, 2008 | 230 | 2008 |
| Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP NA de Vries, T Buckle, J Zhao, JH Beijnen, JHM Schellens, ... Investigational new drugs 30, 443-449, 2012 | 182 | 2012 |
| The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib RL Oostendorp, T Buckle, JH Beijnen, O Van Tellingen, JHM Schellens Investigational new drugs 27, 31-40, 2009 | 182 | 2009 |
| Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals CPW Klerk, RM Overmeer, TMH Niers, HH Versteeg, DJ Richel, T Buckle, ... Biotechniques 43 (sup1), S7-S13, S30, 2007 | 182 | 2007 |
| Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir HA Bardelmeijer, M Ouwehand, T Buckle, MT Huisman, JHM Schellens, ... Cancer research 62 (21), 6158-6164, 2002 | 173 | 2002 |
| Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer OR Brouwer, WMC Klop, T Buckle, L Vermeeren, MWM Van Den Brekel, ... Annals of surgical oncology 19, 1988-1994, 2012 | 151 | 2012 |
| The best of both worlds: a hybrid approach for optimal pre-and intraoperative identification of sentinel lymph nodes GH KleinJan, E Van Werkhoven, NS van Den Berg, MB Karakullukcu, ... European journal of nuclear medicine and molecular imaging 45, 1915-1925, 2018 | 145 | 2018 |
| A self-assembled multimodal complex for combined pre-and intraoperative imaging of the sentinel lymph node T Buckle, AC Van Leeuwen, PTK Chin, H Janssen, SH Muller, J Jonkers, ... Nanotechnology 21 (35), 355101, 2010 | 115 | 2010 |
| Multidrug resistance protein 2 is an important determinant of paclitaxel pharmacokinetics JS Lagas, ML Vlaming, O van Tellingen, E Wagenaar, RS Jansen, ... Clinical cancer research 12 (20), 6125-6132, 2006 | 114 | 2006 |
| Improved brain penetration and antitumor efficacy of temozolomide by inhibition of ABCB1 and ABCG2 MC de Gooijer, NA de Vries, T Buckle, LCM Buil, JH Beijnen, W Boogerd, ... Neoplasia 20 (7), 710-720, 2018 | 110 | 2018 |
| Artificial intelligence and robotics: a combination that is changing the operating room I Andras, E Mazzone, FWB van Leeuwen, G De Naeyer, ... World journal of urology 38, 2359-2366, 2020 | 105 | 2020 |
| Image navigation as a means to expand the boundaries of fluorescence-guided surgery OR Brouwer, T Buckle, A Bunschoten, J Kuil, AL Vahrmeijer, T Wendler, ... Physics in Medicine & Biology 57 (10), 3123, 2012 | 103 | 2012 |
| Imaging agents for the chemokine receptor 4 (CXCR4) J Kuil, T Buckle, FWB van Leeuwen Chemical Society Reviews 41 (15), 5239-5261, 2012 | 99 | 2012 |
| Targeted non-covalent self-assembled nanoparticles based on human serum albumin A Bunschoten, T Buckle, J Kuil, GD Luker, KE Luker, OE Nieweg, ... Biomaterials 33 (3), 867-875, 2012 | 98 | 2012 |
| Synthesis and preclinical characterization of the PSMA-targeted hybrid tracer PSMA-I&F for nuclear and fluorescence imaging of prostate cancer M Schottelius, A Wurzer, K Wissmiller, R Beck, M Koch, D Gorpas, J Notni, ... Journal of Nuclear Medicine 60 (1), 71-78, 2019 | 94 | 2019 |
